Orca Bio Announces $250M in Aggregate Financing in Preparation for Potential Commercialization
Series F, closed in December 2025, builds on recent financing activity to support launch readiness leading up to the Orca-T ® PDUFA date of April 6, 2026 Funding also enables pipeline advancements including new and expanded clinical…
